Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
出版年份 2016 全文链接
标题
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
作者
关键词
Parkinson’s disease, Alpha synuclein, Cerebrospinal fluid biomarkers, Amyloid oligomers, Biomarkers
出版物
Molecular Neurodegeneration
Volume 11, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-01-19
DOI
10.1186/s13024-016-0072-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interference from Heterophilic Antibodies in Amyloid-β Oligomer ELISAs
- (2017) Dag Sehlin et al. JOURNAL OF ALZHEIMERS DISEASE
- Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils
- (2015) Mustafa T. Ardah et al. NEUROBIOLOGY OF DISEASE
- Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
- (2015) Nishant N. Vaikath et al. NEUROBIOLOGY OF DISEASE
- Increased CSF α-synuclein levels in Alzheimer's disease: Correlation with tau levels
- (2014) Sylvie Slaets et al. Alzheimers & Dementia
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
- (2014) Tessandra Stewart et al. AMERICAN JOURNAL OF PATHOLOGY
- Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
- (2014) Edward Rockenstein et al. BRAIN
- Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease
- (2014) Yaroslau Compta et al. JOURNAL OF NEUROLOGY
- Alpha-synuclein and tau: teammates in neurodegeneration?
- (2014) Simon Moussaud et al. Molecular Neurodegeneration
- Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease
- (2014) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease
- (2014) Anke A. Dijkstra et al. MOVEMENT DISORDERS
- CSF biomarkers and clinical progression of Parkinson disease
- (2014) S. Hall et al. NEUROLOGY
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
- (2014) Mustafa T. Ardah et al. Frontiers in Aging Neuroscience
- Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers
- (2014) Jan O. Aasly et al. Frontiers in Aging Neuroscience
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
- (2013) K. D. van Dijk et al. EUROPEAN JOURNAL OF NEUROLOGY
- Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
- (2012) Min Jeong Park et al. Journal of Clinical Neurology
- Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease
- (2012) J. M. Milber et al. NEUROLOGY
- Baicalein Inhibits Formation of α-Synuclein Oligomers within Living Cells and Prevents Aβ Peptide Fibrillation and Oligomerisation
- (2011) Jia-Hong Lu et al. CHEMBIOCHEM
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies
- (2009) K. E. Paleologou et al. BRAIN
- Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
- (2009) C. Mulder et al. CLINICAL CHEMISTRY
- Diagnosis and the premotor phase of Parkinson disease
- (2009) E. Tolosa et al. NEUROLOGY
- Incidental Lewy Body Disease and Preclinical Parkinson Disease
- (2008) Anthony DelleDonne et al. ARCHIVES OF NEUROLOGY
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood
- (2008) Robin Barbour et al. Neurodegenerative Diseases
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now